HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,255,532 | +5.2% | 80,995 | 0.0% | 0.28% | +17.2% |
| Q2 2023 | $6,895,914 | +2.9% | 80,995 | 0.0% | 0.24% | +1.3% |
| Q1 2023 | $6,702,336 | +5.2% | 80,995 | 0.0% | 0.24% | -5.2% |
| Q4 2022 | $6,370,257 | -3.3% | 80,995 | -9.0% | 0.25% | -4.2% |
| Q3 2022 | $6,588,000 | +2.6% | 88,995 | -9.6% | 0.26% | +7.9% |
| Q2 2022 | $6,420,000 | +2.6% | 98,495 | -0.5% | 0.24% | +30.3% |
| Q1 2022 | $6,258,000 | +5.4% | 98,995 | -11.6% | 0.18% | +20.9% |
| Q4 2021 | $5,940,000 | -40.1% | 111,995 | -20.3% | 0.15% | -42.5% |
| Q3 2021 | $9,918,000 | -1.6% | 140,495 | -7.1% | 0.27% | -5.7% |
| Q2 2021 | $10,079,000 | -40.8% | 151,245 | -1.3% | 0.28% | -45.1% |
| Q1 2021 | $17,012,000 | -6.5% | 153,245 | 0.0% | 0.51% | -5.5% |
| Q4 2020 | $18,198,000 | +35.3% | 153,245 | -0.6% | 0.54% | +10.1% |
| Q3 2020 | $13,449,000 | -5.6% | 154,145 | -3.1% | 0.49% | -5.7% |
| Q2 2020 | $14,253,000 | -10.1% | 159,145 | 0.0% | 0.52% | -32.1% |
| Q1 2020 | $15,860,000 | -13.0% | 159,145 | +0.3% | 0.77% | +1.0% |
| Q4 2019 | $18,229,000 | -9.0% | 158,650 | -0.1% | 0.76% | -13.8% |
| Q3 2019 | $20,023,000 | +4.8% | 158,735 | 0.0% | 0.89% | +8.4% |
| Q2 2019 | $19,102,000 | +35.4% | 158,735 | -1.6% | 0.82% | +24.9% |
| Q1 2019 | $14,105,000 | -38.2% | 161,235 | -29.3% | 0.65% | -46.3% |
| Q4 2018 | $22,811,000 | -15.0% | 228,000 | -2.6% | 1.22% | +3.8% |
| Q3 2018 | $26,835,000 | +27.8% | 234,200 | 0.0% | 1.17% | +8.1% |
| Q2 2018 | $21,003,000 | +18.4% | 234,200 | -3.4% | 1.08% | +7.4% |
| Q1 2018 | $17,734,000 | -27.5% | 242,400 | -42.5% | 1.01% | -31.4% |
| Q4 2017 | $24,469,000 | +27.6% | 421,296 | -1.5% | 1.47% | +22.8% |
| Q3 2017 | $19,182,000 | +10.5% | 427,496 | -2.7% | 1.20% | +7.1% |
| Q2 2017 | $17,352,000 | -19.9% | 439,396 | -17.7% | 1.12% | -26.8% |
| Q1 2017 | $21,656,000 | -5.1% | 533,796 | -6.0% | 1.53% | -13.5% |
| Q4 2016 | $22,829,000 | +10.1% | 567,896 | -0.8% | 1.77% | +10.9% |
| Q3 2016 | $20,732,000 | -15.2% | 572,536 | -18.1% | 1.59% | -25.4% |
| Q1 2016 | $24,462,000 | +7.9% | 699,316 | -0.6% | 2.14% | +6.1% |
| Q4 2015 | $22,677,000 | +1.3% | 703,376 | +1.6% | 2.01% | -13.2% |
| Q3 2015 | $22,380,000 | -19.6% | 692,456 | +2.9% | 2.32% | -12.5% |
| Q2 2015 | $27,840,000 | -8.9% | 673,116 | -1.0% | 2.65% | -11.8% |
| Q1 2015 | $30,555,000 | +19.6% | 680,210 | -0.3% | 3.01% | +8.4% |
| Q4 2014 | $25,539,000 | +7.0% | 682,496 | -0.1% | 2.77% | -0.2% |
| Q3 2014 | $23,867,000 | +1.3% | 683,470 | +2.4% | 2.78% | +4.9% |
| Q2 2014 | $23,555,000 | +0.6% | 667,670 | -7.1% | 2.65% | -4.1% |
| Q1 2014 | $23,412,000 | -24.6% | 718,380 | -2.5% | 2.76% | -28.3% |
| Q4 2013 | $31,044,000 | +11.0% | 736,870 | +5.1% | 3.85% | +2.5% |
| Q3 2013 | $27,957,000 | -0.3% | 701,020 | +3.4% | 3.75% | -10.9% |
| Q2 2013 | $28,044,000 | – | 678,220 | – | 4.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |